Oncology Views & Analysis

Views & Analysis

Digital

Tackling ongoing staffing burnout rates through AI-enabled p...

The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Oncology

How can digital and AI optimise the delivery of patient supp...

How can digital and AI optimise the delivery of patient support programs in cancer?

Digital

Ovarian cancer, Olivia, and the OCC – part one

Following the European Society of Gynaecological Oncology (ESGO) 2022 congress, pharmaphorum spoke with experts from among the Ovarian Cancer Commitment (OCC) founding partners – ESGO, the

Oncology

JP Morgan 2023 - Raj Chopra

On the sidelines of JP Morgan 2023, pharmaphorum editor-in-chief Jonah Comstock sat down with Raj Chopra, acting CEO of Aethon Therapeutics.

Oncology

Cancer control in a time of crisis - the pharmaphorum podcas...

During The Economist’s 8th Annual World Cancer Series congress in Brussels November last year, web editor Nicole Raleigh sat down to discuss the event and its themes with

Digital

A few of 2022’s biggest pharma trends – the pharmaphorum pod...

As we close out the year, pharmaphorum's editorial team sat down together for a roundtable discussion of some of the biggest trends they tracked this year in the world of

Tackling ongoing staffing burnout rates through AI-enabled p...

How can digital and AI optimise the delivery of patient supp...

Ovarian cancer, Olivia, and the OCC – part one

JP Morgan 2023 - Raj Chopra

Cancer control in a time of crisis - the pharmaphorum podcas...

A few of 2022’s biggest pharma trends – the pharmaphorum pod...

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Views & Analysis

Editor's Picks